Dr.Suzanne Schwartz’s programmatic efforts in medical device cybersecurity extend beyond incident response to include raising awareness, educating, outreach, partnering and coalition-building within the Healthcare and Public Health Sector (HPH) as well as fostering collaborations across other government agencies and the private sector. Suzanne has been recognized for Excellence in Innovation at FDA’s Women’s History Month on March 1st 2018 for her work in Medical Device Cybersecurity. Suzanne chairs CDRH’s Cybersecurity Working Group, tasked with formulating FDA’s medical device cybersecurity policy. She also co-chairs the Government Coordinating Council (GCC) for the HPH Critical Infrastructure Sector, focusing on the sector’s healthcare cybersecurity initiatives.